Re: 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men with Prostate Cancer

被引：0
|
作者：
Kaplan, Steven A.
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 196卷 / 05期
关键词：
D O I：
10.1016/j.juro.2016.08.044
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1506 / 1506
页数：1
相关论文
共 50 条
  • [21] 5-ALPHA-REDUCTASE INHIBITORS IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Dai, Charles
    Ganesan, Vishnu
    Zabell, Joseph
    Nyame, Yaw
    Hettel, Daniel
    Almassi, Nima
    Greene, Daniel
    Haywood, Samuel
    Reichard, Chad
    Zampini, Anna
    Crane, Alice
    Arora, Hans
    El-Shafei, Ahmed
    Stein, Robert
    Fareed, Khaled
    Gong, Michael
    Jones, J. Stephen
    Stephenson, Andrew
    Klein, Eric
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E229 - E229
  • [22] Re: The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
    Van Cangh, Paul J.
    [J]. EUROPEAN UROLOGY, 2011, 60 (05) : 1122 - 1122
  • [23] 5-alpha Reductase Inhibitors and Prostate Cancer Incidence and Mortality among Men with Benign Prostatic Hyperplasia
    Bhaskaran, Krishnan
    Douglas, Ian
    Smeeth, Liam
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 479 - 479
  • [24] IMPACT OF COMPETING MORTALITY ON THE CANCER-RELATED MORTALITY IN LOCALIZED PROSTATE-CANCER
    AUS, G
    PILEBLAD, E
    HUGOSSON, J
    [J]. UROLOGY, 1995, 46 (05) : 672 - 675
  • [25] THE ASSOCIATION BETWEEN 5-ALPHA REDUCTASE INHIBITORS AND PROSTATE CANCER MORTALITY
    Hamilton, Robert J.
    Chavarriaga, Julian
    Khurram, Najia
    Lau, Cindy
    Luo, Jin
    Liu, Ning
    Komisarenko, Maria
    Kulkarni, Girish
    Wallis, Cristopher
    Fleshner, Neil
    Finelli, Antonio
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E1111 - E1111
  • [26] Prostate cancer chemoprevention with 5α-reductase inhibitors
    Nepple, Kenneth G.
    Andriole, Gerald L.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (05) : 553 - 554
  • [27] Cancer-related morbidity at the end of life in men with prostate cancer.
    Yerramilli, Divya
    Walsh, Eleanor
    Turner, Emma
    Young, Grace
    Nipp, Ryan David
    Donovan, Jenny
    Hamdy, Freddie
    David, Neal
    Martin, Richard
    Temel, Jennifer S.
    Zietman, Anthony L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer
    Ross, Ashley E.
    Feng, Zhaoyong
    Pierorazio, Phillip M.
    Landis, Patricia
    Walsh, Patrick C.
    Carter, H. Ballentine
    Trock, Bruce J.
    Schaeffer, Edward M.
    [J]. BJU INTERNATIONAL, 2012, 110 (05) : 651 - 657
  • [29] OBESITY AND DIABETES: THE INCREASED RISK OF CANCER AND CANCER-RELATED MORTALITY
    Gallagher, Emily Jane
    LeRoith, Derek
    [J]. PHYSIOLOGICAL REVIEWS, 2015, 95 (03) : 727 - 748
  • [30] 5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care
    Vaselkiv, Jane B.
    Ceraolo, Carl
    Wilson, Kathryn M.
    Pernar, Claire H.
    Rencsok, Emily M.
    Stopsack, Konrad H.
    Grob, Sydney T.
    Plym, Anna
    Giovannucci, Edward L.
    Olumi, Aria F.
    Kibel, Adam S.
    Preston, Mark A.
    Mucci, Lorelei A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (07) : 1460 - 1465
12345